Number of Shares
4,914.00
Current Holdings Value*
$4.06 Mil
% of Portfolio
9.37%
Total Estimate Gain
$-266,130.12
% of Total Estimate Gain
-5.24%

AlphaCentric Life Sciences and Healthcare Fund's Eli Lilly and Co Holding Summary

As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held 4,914.00 shares of Eli Lilly and Co(LLY), totaling $4.06 Mil. This investment constitutes 9.37% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding Eli Lilly and Co(LLY) stock.

The initial trade took place in 2024Q4. And since then AlphaCentric Life Sciences and Healthcare Fund has made 1 purchases of LLY, at an average price of $827.11, for a total of 6,140.00 shares. In addition, there have been 1 sales at an average price of $832.09 for 1,226.00 shares. Based on historical transaction data and LLY's current price of $771.71, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his LLY holdings is $-266,130.12, reflecting a -5.24% gain to date.

AlphaCentric Life Sciences and Healthcare Fund LLY ($771.71) Holding Chart

AlphaCentric Life Sciences and Healthcare Fund LLY ($771.71) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1